Combining 1-methyltryptophan, which inhibits IDO, with dual immune checkpoint blockade significantly improved survival in an orthotropic mouse GBM model correlating with increased T-cell survival and synergistic decrease of Treg infiltration [76]. This evidence concerns the gene IDO1 and glioblastoma.